Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases
Hannah C. Moore, Jeffrey Cannon, David C. Kaslow, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 7, pp. 1245-1254
Open Access | Times Cited: 10

Showing 10 citing articles:

The Streptococcus pyogenes vaccine landscape
Donald R. Walkinshaw, Meghan E. E. Wright, Anne E. Mullin, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 53
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary
Deborah King, Helen Groves, Charlie Weller, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Characterization of Streptococcus pyogenes Strains from Tonsillopharyngitis and Scarlet Fever Resurgence, 2023—FIRST Detection of M1UK in Bulgaria
Emma Keuleyan, Т. Тодоров, Deyan Donchev, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 179-179
Open Access
Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring
Edwin J. Asturias, Jean‐Louis Excler, James Ackland, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 6, pp. 917-924
Open Access | Times Cited: 10
The intricate pathogenicity of group a Streptococcus : A comprehensive update
Helena Bergsten, Victor Nizet
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease—streptococcal vaccine development: a national heart, lung and blood institute workshop report
Alma Fulurija, Madeleine W. Cunningham, Natalia Korotkova, et al.
BMJ Global Health (2023) Vol. 8, Iss. Suppl 9, pp. e013534-e013534
Open Access | Times Cited: 4
A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritization
Donald R. Walkinshaw, Meghan E. E. Wright, Marni Williams, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases
Hannah C. Moore, Kate M Miller, Jonathan R. Carapetis, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. Supplement_1, pp. S1-S4
Open Access | Times Cited: 5
[Research progress on the mechanism of -lactam resistance in group A
Meng-Yang Guo, Kaihu Yao
PubMed (2024) Vol. 26, Iss. 1, pp. 92-97
Closed Access
Rhumatisme articulaire aigu chez l’enfant
J Mercier, Romain Basmaci
EMC - Cardiologie (2023) Vol. 37, Iss. 4, pp. 1-5
Closed Access
Page 1

Scroll to top